The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors in patients with hormone receptor positive metastatic breast cancer
Seth A Wander,
Gabriela N. Johnson,
Maxwell R. Lloyd,
Kailey J Kowalski,
Adrienne G Waks,
Lacey M. Litchfield,
Xiang S. Ye,
Chun Ping Yu,
Valerie M. Jansen,
John R. Stille,
Patricia S. Smith,
Gerard J. Oakley,
Jill D. Kremer,
Levi A. Garraway,
Eric P Winer,
Sara M. Tolaney,
Nancy U Lin,
Posted 28 Nov 2019
bioRxiv DOI: 10.1101/857839 (published DOI: 10.1158/2159-8290.CD-19-1390)
Posted 28 Nov 2019
Clinical resistance mechanisms to CDK4/6 inhibitors in HR+ breast cancer have not been clearly Whole exome sequencing of 59 tumors with CDK4/6i exposure revealed multiple candidate resistance mechanisms including RB1 loss, activating alterations in AKT1, RAS, AURKA, CCNE2, ERBB2, and FGFR2, and loss of ER expression. In vitro experiments confirmed that these alterations conferred CDK4/6i resistance. Cancer cells cultured to resistance with CDK4/6i also acquired RB1, KRAS, AURKA, or CCNE2 alterations, which conferred sensitivity to AURKA, ERK, or CHEK1 inhibition. Besides inactivation of RB1, which accounts for ~5% of resistance, seven of these mechanisms have not been previously identified as clinical mediators of resistance to CDK4/6 inhibitors in patients. Three of these - RAS activation, AKT activation, and AURKA activation - have not to our knowledge been previously demonstrated preclinically. Together, these eight mechanisms were present in 80% of resistant tumors profiled and may define therapeutic opportunities in patients.
- Downloaded 871 times
- Download rankings, all-time:
- Site-wide: 14,335 out of 89,581
- In cancer biology: 412 out of 3,161
- Year to date:
- Site-wide: 3,670 out of 89,581
- Since beginning of last month:
- Site-wide: 6,918 out of 89,581
Downloads over time
Distribution of downloads per paper, site-wide
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!